This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Landauer, Inc. Appoints Greg Groenke To President Of IZI Medical Products

GLENWOOD, Ill., Oct. 4, 2012 /PRNewswire/ -- Landauer, Inc. (NYSE: LDR), a recognized leader in personal and environmental radiation measurement and monitoring, outsourced medical physics services and high quality medical consumable accessories, today announced that it appointed Greg Groenke to President of Landauer's IZI Medical Products business effective immediately.

"Greg is an experienced healthcare professional with a proven track record of leadership and strong operating results," said Bill Saxelby, President and Chief Executive Officer of Landauer, Inc. "Greg's demonstrated proficiency in strategy and product development, along with his medical device regulatory and manufacturing experience within the surgical, orthopedic spine and interventional radiology segments, will enable him to make an immediate impact on our organization."

In this role, Mr. Groenke will set and lead the strategic and operating direction for the IZI Medical Products business. Prior to Landauer, Mr. Groenke served as Senior Vice President/General Manager of Environmental Technologies at Cardinal Health, where he was responsible for a $650 million global business. He has extensive experience in medical device product development and was responsible for business development earlier in his career with Cardinal Health. Prior to joining Cardinal Health, Greg worked for Johnson and Johnson's Ethicon Endo – Surgery business.

Mr. Groenke earned a Master in Business Administration from The University of Minnesota's Carlson School of Management and a Bachelor of Mechanical Engineering from The University of Minnesota.

"Landauer is a world leader in radiation science and services, and I am delighted to join such a dynamic, innovative company," said Mr. Groenke. "I believe there are extraordinary opportunities to grow and build shareholder value as we achieve our strategic growth initiatives. I look forward to working closely with the IZI employees, as well as our customers, shareholders and business partners."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs